1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6C3FA35D07D4388070025853C00475007
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-apac-msl-excellence-optimizing-alignment-assessment-field-medical-operations-asia-pacific?opendocument
18
19opendocument
203.226.97.214
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Medical Affairs Medical Science Liaison

APAC MSL excellence: Optimizing alignment and assessment for field medical operations in Asia-Pacific

ID: 5608


Features:

15 Info Graphics

29 Data Graphics

610+ Metrics

10 Narratives


Pages/Slides: 51


Published: 2020


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “APAC MSL excellence: Optimizing alignment and assessment for field medical operations in Asia-Pacific”


STUDY OVERVIEW

As medical science liaisons (MSLs) continue to play an important role in accessing and engaging key thought leaders in the Asia-Pacific (APAC) region, the country-specific dynamics of a market affect how pharmaceutical field medical teams are organized and evaluated.

Thus it’s important to have teams appropriately aligned to each country to ensure the team’s success.

Best Practices, LLC conducted this benchmarking research to examine how leading pharmaceutical and biotechnology companies structure, align and support their MSL teams in the APAC region. The study also captures APAC region and country-level field metrics on MSL productivity, efficiency, KOL and key account targeting, interaction frequency, communication and tools, skills and background.

Insights in this research are presented into following segments to illuminate field medical trends at region and country level: Europe Segment (N=58), APAC Segment (N=30), Americas Segment (N=27), MENA Segment (N=9).

KEY TOPICS

  • Structure and alignment of MSL teams
  • MSL productivity and efficiency
  • KOL and key account targeting and engagement
  • MSL skills and background across markets in APAC region

KEY METRICS
  • What is the reporting relationship between the MSLs in each country and your global Medical Affairs organization?
  • In your region, approximately how much time do your MSLs spend on average on the listed activity areas per week?
  • On average, how many thought leaders do each of your MSLs support in your region?
  • For a typical MSL in APAC, approximately what percentage of all targeted thought leaders can be classified according to the listed tiers?
  • How many large key accounts (hospitals, care networks or academic institutions) do each of your MSLs support on average in your region?
  • What is your MSL’s average time spent in each face-to-face thought leader interactions in each region (in minutes)?
  • How frequently do your MSLs in each country interact with each kind of thought leader on average?
  • In each region, what percentage of your MSLs’ thought leader interactions are proactive vs. reactive?
  • On average, how many years of MSL experience do your MSLs working in each country have?

SAMPLE KEY FINDINGS
  • Effectiveness: F2F is widely used (72% of engagement) in a region where that manner of in-person interaction is often critical to building genuine relationships. APAC MSLs collectively have the least experience in the role of any global region, with nearly half of current APAC MSLs having previously worked as sales reps. APAC leaders cite both sales reps and physicians as being the most promising professional backgrounds for successful future MSLs.

METHODOLOGY

Best Practices, LLC engaged 125 Global Medical Affairs and Field Medical Excellence leaders from more than 40 leading pharma and biotech companies in this research through a benchmarking survey. In-depth interviews were conducted with 8 benchmark partners to gain further insights. The vast majority of study participants serve at the executive or director level. Together they provide a comprehensive view of field medical operations around the world, from a global, regional and local perspective.

Industries Profiled:
Health Care; Pharmaceutical; Diagnostic; Biotech; Manufacturing; Consumer Products; Medical Device; Chemical; Biopharmaceutical; Clinical Research; Laboratories


Companies Profiled:
Abbott; Alexion Pharmaceuticals; Allergopharma; Amgen; AstraZeneca; Bayer; Biogen; Bioventus; Boehringer Ingelheim; Celgene; Chiesi; Clovis Oncology; Dr Reddy's Laboratories; Eisai; Galderma; GE Healthcare; Gedeon Richter ; Gilead Sciences; Grifols; Ipsen; Janssen; Kiniksa Pharmaceuticals; Kyowa Kirin; Lupin; Merck; MSD; Novartis; Novelion Therapeutics; Pfizer; Rakuten Medical; Roche; Sandoz; Sanofi; Shire; Sunovion; Takeda Pharmaceuticals; UCB Pharma; Vertex Pharmaceuticals; Vifor Pharma; ViiV Healthcare

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.